Perirenal adipose tissue thickness

1. GLP-1 receptor agonists are associated with perirenal adipose tissue thickness in humans (-0.433 cm versus reference (95% CI -0.622 to -0.244); multiple-imputation estimate -0.421 cm (95% CI -0.693 to -0.149)).

   “Adjusted differences versus reference were -0.227 cm (95% CI -0.417 to -0.036) and -0.433 cm (-0.622 to -0.244)”

   HumansCKD Stages 1-4; baseline-adjusted comparison with neither drug classGLP-1RA-based therapyperirenal adipose tissue8 monthsn = 24

   The Effects of GLP-1RA-Based and SGLT2 Inhibitor Therapy on Perirenal Adipose Tissue in CKD Patients

   Diabetes, obesity & metabolism·13 Oct 2026

More on GLP-1 receptor agonists

1. SGLT2 inhibitors are associated with perirenal adipose tissue thickness in humans (-0.227 cm versus reference (95% CI -0.417 to -0.036); multiple-imputation estimate -0.218 cm (95% CI -0.482 to +0.046)).

   “Adjusted differences versus reference were -0.227 cm (95% CI -0.417 to -0.036) and -0.433 cm (-0.622 to -0.244)”

   HumansCKD Stages 1-4; baseline-adjusted comparison with neither drug classperirenal adipose tissue8 monthsn = 24

   The Effects of GLP-1RA-Based and SGLT2 Inhibitor Therapy on Perirenal Adipose Tissue in CKD Patients

   Diabetes, obesity & metabolism·13 Oct 2026

More on SGLT2 inhibitors